Member Info for valueseeker

So they are just going to be issued on Finnish exchange ?

Agree these shares just for scientists, directors, partners/ collaborators/ researchers!

They know the potential here!

Interesting to see that while manifest and his/her colleagues are busy spending all day deramping and knocking the company, the MMS are busy hoovering up shares to fill large orders.

58,000 buy just gone through! Lol

Scored again - only a matter of time.The recent Barron's report highly just how undervalued these offshore explorers are.

Add to that the resurgence of interest in Falkland's development and this will be snapped up by an oil major soon imo.

Scored again - only a matter of time.The recent Barron's report highly just how undervalued these offshore explorers are.

Add to that the resurgence of interest in Falkland's development and this will be snapped up by an oil major soon imo.

Scored again - only a matter of time.The recent Barron's report highly just how undervalued these offshore explorers are.

Add to that the resurgence of interest in Falkland's development and this will be snapped up by an oil major soon imo.

Looks like with the volume here we are seeing some interest from some bigger players - ahead of some developments??

One things for sure , this one' s still very cheap nearly all time low and one day soon something's bound to happen after all these years. I think sealion will go ahead and excitement around Falklands exploration will re ignite

Pmo and rockhopper seeing a bit of a rise today too. Could be related to F Island developments or maybe not?

Mani - you MAY have a few weeks, you MAY have a few days... Better close those shorts SOON!

From my research, there are at least seven potential RNs updates due in the near term - which range from clinical updates, to patent grants, to news in areas such as collaboration and partnering.

I would say not the best time to be short IMO.

Itsall - excellent news, proving again the massive potential of our product in what is the innovative and cutting edge of pharma - the exact space into which all the big boys are hoping to move.

I suppose the derampers can still get a few to sell.

Hold on to your shares.CEO has confirmed that there will be no dilutive placing. The shorts need to buy back and time is running out.

Lol

Lol

The team are really working hard today!

The point is exactly that we HAVE lost 90% of value and the so trashed but the prospects here are as interesting as ever so you recommend selling at this level do you, after a fall of 90%?

If you really think this is a sell now at this bombed out basement level I suggest you find yourself another hobbies!

Manifest - utter rubbish, everyone knows the MKT can be manipulated (not forever as value will ultimately win out) but for a time and for a reason.

Everyone who posts has an agenda.

Posters will decide for themselves what yours is ?

I would be very wary of manifest. He/She claims to be a holder but has spent all weekend knocking the company, even posting at 7:41 today her negativity (just before the open).Weird behaviour for a "supporter" of the company. Are they short/what is their agenda.

Anyway, the good news is really starting to pick up here with both lead products showing excellent promise and (multiple ) partner discussions on both!

I think we are going to be in for a VERY interesting spring

Manifest

Very simple really. The benefits of a partnering deal are far superior Yes, they are going to want to take a share of the success and gains so will askfor a good deal BUT a cash injection of 50/ 75 or 100m will ( even if it is in staged payments will have a dramatic effect on the beaten down ( manipulated down?) share price.

We are now only valued at 18M mkt cap !!

Amazing news from our ceo. Just watched the podcast where he has stated that the company will not be coming to the market for fundraising this year so no dilution and no placings etc.

Very interesting that those with their own agendas have to immediately start knocking what is a very positive update from the co.

We now have partnering discussions taking place on BOTH of our lead products .Traumakine effective on 35% of patients further studies to deal with the steriod interference on the remaining groups of patients. Clevegen showing quite amazing promise in re- activating the natural killer cells (T and other) which is effectively a new area and NEW discovery in this area of treatment.

Despite last years setback , the outlook imo is as as good as it gets ( only we are at 59p NOT 850p!). Will be looking to add on Monday

Would be looking to purchase 15 - 20k at 50 - 55 p level if poss ( maybe slightly more if nearer 50 p level). tia

Manifesto's posts are inaccurate and misleading. The company never broke off talks with partners. Traumakine works for 35% of patients regardless of whether they are using steroids or not.Yoda is evaluating effectness for rest of patients and if steroids are not administered the drug is effective in this group AS WELL. Lots of misleading inaccuracies in his/her posts.